Literature DB >> 10022884

All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity.

H Y Lee1, N Sueoka, W K Hong, D J Mangelsdorf, F X Claret, J M Kurie.   

Abstract

Jun N-terminal kinases (JNKs) are serine-threonine kinases that play a critical role in the regulation of cell growth and differentiation. We previously observed that JNK activity is suppressed by all-trans-retinoic acid (t-RA), a ligand for retinoic acid nuclear receptors (RARs), in normal human bronchial epithelial cells, which are growth inhibited by t-RA. In this study, we investigated the mechanism by which t-RA inhibits JNK and the possibility that this signaling event is blocked in non-small cell lung cancer (NSCLC) cells. Virtually all NSCLC cell lines are resistant to the growth-inhibitory effects of t-RA, and a subset of them have a transcriptional defect specific to retinoid nuclear receptors. We found that in NSCLC cells expressing functional retinoid receptors, serum-induced JNK phosphorylation and activity were inhibited by t-RA in a bimodal pattern, transiently within 30 min and in a sustained fashion beginning at 12 h. Retinoid receptor transcriptional activation was required for the late, but not the early, suppression of JNK activity. t-RA inhibited serum-induced JNK activity by blocking mitogen-activated protein (MAP) kinase kinase 4-induced signaling events. This effect of t-RA was phosphatase dependent and involved an increase in the expression of the dual-specificity MAP kinase phosphatase 1 (MKP-1). t-RA did not activate MKP-1 expression or inhibit JNK activity in a NSCLC cell line with retinoid receptors that are refractory to ligand-induced transcriptional activation. These findings provide the first evidence that t-RA suppresses JNK activity by inhibiting JNK phosphorylation. Retinoid receptor transcriptional activation was necessary for the sustained inhibition of JNK activity by t-RA, and this signaling event was disrupted in NSCLC cells with retinoid receptors that are refractory to ligand-induced transcriptional activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022884      PMCID: PMC83990          DOI: 10.1128/MCB.19.3.1973

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase.

Authors:  M Muda; U Boschert; R Dickinson; J C Martinou; I Martinou; M Camps; W Schlegel; S Arkinstall
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

2.  Post-translational modification of human brain type I inositol-1,4,5-trisphosphate 5-phosphatase by farnesylation.

Authors:  F De Smedt; A Boom; X Pesesse; S N Schiffmann; C Erneux
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

3.  Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor.

Authors:  A J Hörlein; A M Näär; T Heinzel; J Torchia; B Gloss; R Kurokawa; A Ryan; Y Kamei; M Söderström; C K Glass
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

4.  A transcriptional co-repressor that interacts with nuclear hormone receptors.

Authors:  J D Chen; R M Evans
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

5.  Integration of MAP kinase signal transduction pathways at the serum response element.

Authors:  A J Whitmarsh; P Shore; A D Sharrocks; R J Davis
Journal:  Science       Date:  1995-07-21       Impact factor: 47.728

6.  Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors.

Authors:  Y H Kim; D F Dohi; G R Han; C P Zou; N Oridate; G L Walsh; J C Nesbitt; X C Xu; W K Hong; R Lotan
Journal:  Cancer Res       Date:  1995-12-01       Impact factor: 12.701

7.  Purification and characterization of the low molecular weight protein tyrosine phosphatase, Stp1, from the fission yeast Schizosaccharomyces pombe.

Authors:  Z Y Zhang; G Zhou; J M Denu; L Wu; X Tang; O Mondesert; P Russell; E Butch; K L Guan
Journal:  Biochemistry       Date:  1995-08-22       Impact factor: 3.162

8.  High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.

Authors:  W W Zhang; X Fang; W Mazur; B A French; R N Georges; J A Roth
Journal:  Cancer Gene Ther       Date:  1994-03       Impact factor: 5.987

9.  Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.

Authors:  S A Oñate; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

10.  A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.

Authors:  Y Kamei; L Xu; T Heinzel; J Torchia; R Kurokawa; B Gloss; S C Lin; R A Heyman; D W Rose; C K Glass; M G Rosenfeld
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

View more
  24 in total

1.  Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage.

Authors:  Frédéric Bost; Leslie Caron; Irène Marchetti; Christian Dani; Yannick Le Marchand-Brustel; Bernard Binétruy
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

2.  Kinase-dependent, retinoic acid receptor-independent up-regulation of cyclooxygenase-2 by all-trans retinoic acid in human mesangial cells.

Authors:  M Alique; V Moreno; M Kitamura; Q Xu; F J Lucio-Cazana
Journal:  Br J Pharmacol       Date:  2006-08-07       Impact factor: 8.739

3.  Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.

Authors:  S Reffas; W Schlegel
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

4.  Vitamin A inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosis.

Authors:  J A McCarroll; P A Phillips; N Santucci; R C Pirola; J S Wilson; M V Apte
Journal:  Gut       Date:  2005-07-25       Impact factor: 23.059

5.  c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha.

Authors:  Harish Srinivas; Denise M Juroske; Shailaja Kalyankrishna; Dianna D Cody; Roger E Price; Xiao-Chun Xu; Ramesh Narayanan; Nancy L Weigel; Jonathan M Kurie
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

6.  Combined α-tocopherol and ascorbic acid protects against smoke-induced lung squamous metaplasia in ferrets.

Authors:  Yuri Kim; Nalinee Chongviriyaphan; Chun Liu; Robert M Russell; Xiang-Dong Wang
Journal:  Lung Cancer       Date:  2011-06-12       Impact factor: 5.705

7.  Animal models in carotenoids research and lung cancer prevention.

Authors:  Jina Kim; Yuri Kim
Journal:  Transl Oncol       Date:  2011-10-01       Impact factor: 4.243

Review 8.  Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment.

Authors:  Roisin M Connolly; Nguyen K Nguyen; Saraswati Sukumar
Journal:  Clin Cancer Res       Date:  2013-01-15       Impact factor: 12.531

9.  Retinoic acid-elicited RARα/RXRα signaling attenuates Aβ production by directly inhibiting γ-secretase-mediated cleavage of amyloid precursor protein.

Authors:  Arun Kapoor; Bo-Jeng Wang; Wen-Ming Hsu; Ming-Yun Chang; Shu-Mei Liang; Yung-Feng Liao
Journal:  ACS Chem Neurosci       Date:  2013-04-15       Impact factor: 4.418

10.  Gene expression profiling during all-trans retinoic acid-induced cell differentiation of acute promyelocytic leukemia cells.

Authors:  Lijun Yang; Hongshan Zhao; Shi-Wu Li; Kim Ahrens; Christine Collins; Sarah Eckenrode; Qing-guo Ruan; Richard A McIndoe; Jin-Xiong She
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.